• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Allowing Bedside Nurses to Order C. Difficile Testing Cuts Time to Results

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, May 26, 2023 -- Allowing bedside nurses to independently order stool testing for Clostridioides difficile (C. difficile) significantly decreases the amount of time to receive test results versus requiring physician approval, according to a study published online May 10 in the American Journal of Infection Control.

Ashley Bartlett, M.D., from the Fargo Veterans Affairs Healthcare System in North Dakota, and colleagues evaluated the impact of a policy that allowed bedside nurses to order C. difficile testing on the time to obtain test results and initiate treatment. The analysis included results from a single Veterans Affairs system site 44 months prior to and 59 months after the change in policy.

The researchers found that the difference in time to obtain the result before and after the policy change was statistically significant. Additionally, the difference in time to obtain the result significantly differed by ordering provider type, with nurses significantly associated with faster test results compared with physicians (odds ratio, 1.72). There was no significant difference observed in time to initiate treatment (1.7 hours before and after policy change).

"Given the implications of C. difficile infection on both a hospital and patient level, incentives exist for improving approaches to the prevention and spread of this infection in the clinical environment," Bartlett in a statement. "Our findings suggest that allowing bedside nurses with appropriate training to order C. diff testing based on patient symptomology could be a valid strategy to help health care systems achieve this goal."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted May 2023

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.